Ortoma AB (publ) (STO:ORT.B)

Theseus Pharmaceuticals Statistics

Total Valuation

Ortoma AB has a market cap or net worth of SEK 841.80 million. The enterprise value is 791.96 million.

Market Cap	841.80M
Enterprise Value	791.96M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Ortoma AB has 37.08 million shares outstanding. The number of shares has increased by 2.04% in one year.

Current Share Class	35.42M
Shares Outstanding	37.08M
Shares Change (YoY)	+2.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	27.72%
Owned by Institutions (%)	0.01%
Float	26.70M

Valuation Ratios

The trailing PE ratio is 137.71.

PE Ratio	137.71
Forward PE	n/a
PS Ratio	9.34
PB Ratio	4.69
P/TBV Ratio	4.71
P/FCF Ratio	24.91
P/OCF Ratio	24.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 133.59, with an EV/FCF ratio of 23.44.

EV / Earnings	129.56
EV / Sales	8.79
EV / EBITDA	133.59
EV / EBIT	148.91
EV / FCF	23.44

Financial Position

The company has a current ratio of 4.62

Current Ratio	4.62
Quick Ratio	3.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	844.08

Financial Efficiency

Return on equity (ROE) is 3.47% and return on invested capital (ROIC) is 1.88%.

Return on Equity (ROE)	3.47%
Return on Assets (ROA)	1.74%
Return on Invested Capital (ROIC)	1.88%
Return on Capital Employed (ROCE)	2.94%
Revenue Per Employee	9.01M
Profits Per Employee	611,273
Employee Count	10
Asset Turnover	0.47
Inventory Turnover	3.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.54% in the last 52 weeks. The beta is 0.64, so Ortoma AB's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+133.54%
50-Day Moving Average	15.83
200-Day Moving Average	10.77
Relative Strength Index (RSI)	56.58
Average Volume (20 Days)	216,951

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ortoma AB had revenue of SEK 90.09 million and earned 6.11 million in profits. Earnings per share was 0.16.

Revenue	90.09M
Gross Profit	44.26M
Operating Income	5.32M
Pretax Income	6.11M
Net Income	6.11M
EBITDA	5.93M
EBIT	5.32M
Earnings Per Share (EPS)	0.16

Balance Sheet

The company has 49.84 million in cash and n/a in debt, giving a net cash position of 49.84 million or 1.34 per share.

Cash & Cash Equivalents	49.84M
Total Debt	n/a
Net Cash	49.84M
Net Cash Per Share	1.34
Equity (Book Value)	179.47M
Book Value Per Share	4.84
Working Capital	54.72M

Cash Flow

In the last 12 months, operating cash flow was 33.97 million and capital expenditures -180,057, giving a free cash flow of 33.79 million.

Operating Cash Flow	33.97M
Capital Expenditures	-180,057
Free Cash Flow	33.79M
FCF Per Share	0.91

Margins

Gross margin is 49.13%, with operating and profit margins of 5.90% and 6.79%.

Gross Margin	49.13%
Operating Margin	5.90%
Pretax Margin	6.79%
Profit Margin	6.79%
EBITDA Margin	6.58%
EBIT Margin	5.90%
FCF Margin	37.51%

Dividends & Yields

Ortoma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.04%
Shareholder Yield	n/a
Earnings Yield	0.73%
FCF Yield	4.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ortoma AB has an Altman Z-Score of 14.05 and a Piotroski F-Score of 7.

Altman Z-Score	14.05
Piotroski F-Score	7